Regeneron Pharmaceuticals, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue4.29B3.61B3.88B3.75B3.68B3.03B3.79B3.72B
Cost of Goods Sold805.4M669.4M584.6M521.6M530.2M464.3M565.4M491.1M
Gross Profit3.49B2.94B3.30B3.23B3.15B2.56B3.22B3.23B
R&D Expenses1.63B1.65B1.63B1.56B1.43B1.34B1.43B1.33B
Operating Expenses2.42B2.29B2.42B2.21B2.07B1.97B2.23B2.05B
Operating Income1.29B642.9M879.9M1.03B1.08B591.7M990.2M1.18B
Other Income / Gains234.3M188.3M163.8M736.5M439.2M313.3M-32.1M313.5M
Net Income1.30B727.2M844.6M1.46B1.39B808.7M917.7M1.34B
EPS (Diluted)12.596.998.2114.0913.247.588.5312.40
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.8120.8140.8490.8610.8560.8470.8510.868
General And Administrative Expenses00000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses662.1M647.7M775.0M657.8M634.2M633.0M792.2M714.4M
Other Expenses127.0M018.7M-10.0M0015.5M8.0M
Cost And Expenses3.00B2.96B3.00B2.73B2.60B2.44B2.80B2.54B
Interest Income183.3M183.5M193.3M175.1M174.8M173.5M183.1M187.4M
Interest Expense11.0M12.9M12.2M19.3M3.6M8.7M10.5M13.8M
Depreciation And Amortization0123.2M145.0M136.7M135.1M126.9M126.4M121.7M
Ebitda969.1M967.3M1.20B1.92B1.66B1.04B1.09B1.63B
Ebitdaratio0.2260.2680.3090.5110.4510.3440.2890.438
Operating Income Ratio0.3010.1780.2270.2730.2940.1950.2610.317
Income Before Tax1.53B831.2M1.04B1.76B1.52B905.0M958.1M1.49B
Income Before Tax Ratio0.3560.2310.2690.470.4130.2990.2530.401
Income Tax Expense230.9M104.0M199.1M303.3M127.1M96.3M40.4M152.4M
Net Income Ratio0.3020.2020.2170.3890.3790.2670.2420.36
Epsdiluted12.206.757.8613.6212.817.278.0611.54
Weighted Average Shs Out103.4M104.0M102.9M103.6M105.1M106.7M107.9M108.1M
Weighted Average Shs Out Dil106.8M107.7M107.5M107.2M108.6M111.2M113.8M116.2M